Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
biotech
boston blog main
boston top stories
life sciences
national blog main
new york blog main
azacitidine
beta-thalassemia
beyond meat
boston college
cancer
cannabis
clinical trials
co-founder
codiak biosciences
cutaneous t-cell lymphoma
dacogen
deals
decitabine
dna
drugs
epigenetics
epizyme
exosome
farydak
flagship pioneering
fulcrum therapeutics
insulated genomic domains
james joaquin
jazz pharmaceuticals
kaleido biosciences
mahesh karande
medicine
national top stories
new york top stories
obvious ventures
olly
omega therapeutics
panobinostat
What
based
3
×
new
3
×
medicines
aims
approach
athletes
beam
begin
biosciences
biotech
bio’s
boston
break
brings
bubbles
called
cannabinoid
cannabis
cbd
cells
class
clinical
codiak
company
conditions
debuts
developing
dosed
drugs
epigenetic
epigenetics
exosome
exosomes
field
flagship’s
formed
fund
getting
gnc
hankering
Language
unset
Current search:
new
×
based
×
boston
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@techcrunch.com
4 years ago
Obvious Ventures makes CBD sporty with beam, which sells cannabis products to the GNC set
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
